Metabolic rewiring in myc-driven medulloblastoma by bet-bromodomain inhibition

HIGHLIGHTS

  • who: Vittoria Graziani from the DepartmentQueen Mary University of have published the article: Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition, in the Journal: Scientific Reports Scientific Reports
  • what: The authors focused on the common enriched pathways in which the metabolites myo-inositol, glycerophosphocholine and serine increased significantly upon OTX-015 treatment in both cell lines (Fig 5). The authors discovered that D283 exhibits diverse metabolic characteristics compared to D458 cells, consistent with their different origin and genetic b u00ad ackground28.
  • how: The authors investigated the metabolome of MYC-driven MB . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?